FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

703673007: Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (substance)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3009365018 Sodium glucose cotransporter subtype 2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520826018 Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3559322015 Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


9 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium glucose cotransporter subtype 2 inhibitor est un(e) (attribut) Antidiabetic agent (substance) false Inferred relationship Some
Sodium glucose cotransporter subtype 2 inhibitor est un(e) (attribut) Enzyme inhibitor false Inferred relationship Some
Sodium glucose cotransporter subtype 2 inhibitor est un(e) (attribut) Drug or medicament (substance) true Inferred relationship Some
Sodium glucose cotransporter subtype 2 inhibitor Has disposition (attribute) Sodium glucose cotransporter subtype 2 inhibitor (disposition) true Inferred relationship Some
Sodium glucose cotransporter subtype 2 inhibitor est un(e) (attribut) Substance categorized by disposition false Inferred relationship Some
Sodium glucose cotransporter subtype 2 inhibitor est un(e) (attribut) Substance with cellular transport inhibitor mechanism of action (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Canagliflozin hemihydrate (substance) est un(e) (attribut) True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Dapagliflozin propanediol monohydrate (substance) est un(e) (attribut) True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Ertugliflozin pidolate est un(e) (attribut) True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Remogliflozin etabonate est un(e) (attribut) True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Dapagliflozin (substance) est un(e) (attribut) True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Canagliflozin est un(e) (attribut) True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Empagliflozin est un(e) (attribut) True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Product containing sodium glucose cotransporter subtype 2 inhibitor (product) a pour principe actif (attribut) True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some 1
Ertugliflozin est un(e) (attribut) True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Dapagliflozin propanediol est un(e) (attribut) True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some

This concept is not in any reference sets

Back to Start